证券记录 · 已归档季度
VOR
Vor Biopharma Inc. · Healthcare · Biotechnology
24被追踪持有人
-1Δ持有人
5.67M持有股份
$74.16M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -4.0% ·
股份流向 +30.0% ·
净新建仓位 -4.2%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 46 | +15 | 17.25M | $317.51M | +16 | −1 |
| Q1 2026 | 31 | +7 | 8.52M | $152.06M | +8 | −1 |
| Q4 2025 | 24 | -1 | 5.67M | $74.16M | n/a | −1 |
| Q3 2025 | 11 | +1 | 478.12K | $23.29M | +2 | −1 |
| Q2 2025 | 7 | -2 | 5.57M | $9.03M | n/a | −2 |
| Q1 2025 | 6 | -1 | 1.58M | $1.14M | n/a | −1 |
| Q4 2024 | 7 | 0 | 1.73M | $1.92M | n/a | n/a |
| Q3 2024 | 6 | 0 | 1.74M | $1.22M | +1 | −1 |
| Q2 2024 | 6 | n/a | 1.49M | $1.49M | n/a | n/a |
持有人 · Q4 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 2.53M | +968.1% | $33.04M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 2 | The Vanguard Group ✦ (被动) | 770.25K | +632.2% | $10.07M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 3 | BlackRock ✦ (被动) | 465.64K | +1248.5% | $6.09M | 0.0% | ▲ Add | 3 | SEC ↗ ×8 |
| 4 | Citadel Advisors ✦ | 433.89K | +7530.9% | $5.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | UBS Group AG | 292.12K | n/a | $3.82M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 224.53K | +806.7% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 185.81K | +578.3% | $2.43M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 8 | Tudor Investment Corp Et Al | 167.67K | n/a | $2.19M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Ameriprise Financial Inc | 163.06K | n/a | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 145.64K | +822.6% | $1.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Jane Street Group, Llc | 91.81K | n/a | $1.20M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | State Street Global Advisors ✦ (被动) | 91.05K | +905.7% | $1.19M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Northern Trust Corp | 38.95K | n/a | $509,414 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 28.46K | +538.8% | $372,296 | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 15 | Squarepoint Ops LLC | 18.46K | n/a | $241,444 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Susquehanna International Group, Llp | 14.82K | n/a | $193,833 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Citigroup Inc | 6.34K | n/a | $82,927 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 2.31K | +1382.0% | $30,241 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 19 | Barclays Plc | 1.40K | n/a | $18,299 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Mirae Asset Global Investments Co.… | 819 | n/a | $10,713 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Bank Of America Corp /De/ | 396 | n/a | $5,179 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 22 | Bnp Paribas Financial Markets | 291 | n/a | $3,806 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Wells Fargo & Company/Mn | 1 | n/a | $13 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Royal Bank Of Canada | 7 | n/a | $0 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Renaissance Technologies | $711,312 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 79 持有人, 40.44M 股份, $716.36M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Aug 14
SC 13G/A: Venrock Healthcare Capital Partners…
Aug 14
SC 13G/A: Frazier Life Sciences Public Fund, L.P.
Aug 13
SC 13G/A: Verve Capital Ltd
Aug 07
SC 13G/A: FMR LLC
Aug 06
SC 13G: FMR LLC
Jul 30
SC 13G: BlackRock, Inc.
Jul 21
SC 13D/A: RA CAPITAL MANAGEMENT, L.P.
19.9% 占股份类别 · 查看 SEC 原始申报文件 ↗
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2025 ·
方法论 ·
通过API获取此数据